Baypresol en es it fr

Baypresol Brand names, Baypresol Analogs

Baypresol Brand Names Mixture

  • No information avaliable

Baypresol Chemical_Formula


Baypresol RX_link

Baypresol fda sheet

Baypresol FDA

Baypresol msds (material safety sheet)

Baypresol MSDS

Baypresol Synthesis Reference

No information avaliable

Baypresol Molecular Weight

1270.28 g/mol

Baypresol Melting Point

No information avaliable

Baypresol H2O Solubility

Freely soluble as sodium salt (> 200mg/mL)

Baypresol State


Baypresol LogP

No information avaliable

Baypresol Dosage Forms

Powder for solution (for injection)

Baypresol Indication

For use in the treatment of patients with esophageal candidiasis and prophylaxis of Candida infections in patients undergoing hematopoietic stem cell transplantation.

Baypresol Pharmacology

Formerly known as FK463, micafungin is a novel antifungal agent. It is a glucan synthesis inhibitor of the echinocandin structural class. The U.S. Food and Drug Administration approved micafungin in March 2005. Micafungin inhibits an enzyme essential for fungal cell-wall synthesis and is fungicidal (lethal) for Candida. Micafungin can be used concomitantly with a variety of other drugs, including the HIV protease inhibitor ritonavir and the transplant medications cyclosporine and tacrolimus.

Baypresol Absorption

No information avaliable

Baypresol side effects and Toxicity

Intravenous LD50 in rats is 125mg/kg. In dogs it is >200mg/kg. No cases of overdosage have been reported. Repeated daily doses up to 8 mg/kg (maximum total dose of 896 mg) in adult patients have been administered in clinical trials with no reported dose-limiting toxicity. The minimum lethal dose is 125 mg/kg in rats, equivalent to 8.1 times the recommended human clinical dose for esophageal candidiasis based on body surface area comparisons.

Baypresol Patient Information

No information avaliable

Baypresol Organisms Affected

Aspergillis, Candida and other fungi